Medimaps Group and Radiobotics announce a strategic merger, forming a global leader in AI-driven musculoskeletal imaging and end-to-end bone health diagnostics.

Summary:

  • Strategic Merger: Medimaps Group and Radiobotics have agreed to merge, creating a unified global leader in AI-driven musculoskeletal (MSK) medical imaging.
  • End-to-End Solution: The partnership bridges the gap between reactive fracture detection and preventative bone health management across X-ray and DXA modalities.
  • Global Reach: The combined entity will leverage an expanded commercial network to serve hospitals and imaging centers across 90 countries.

Didier Hans Medimaps
Univ.-Prof. Dr. Didier Hans
Co-founder and CEO of Medimaps Group

“This merger represents a pivotal milestone in Medimaps Group’s long-term strategy to strengthen our leadership in bone health assessment. Our ambition is to give radiologists a single, trusted platform that brings together fracture detection and fracture risk prediction across the continuum of care, so clinicians can make better decisions, patients receive better outcomes, and healthcare systems benefit from more efficient, evidence-based care.”

Written by

Investors

Verve Event Zurich Investors

Our sophisticated investors include visionary family offices, leading wealth managers, institutions, founders, and senior executives. These individuals and organizations are all committed to shaping the next generation of innovation.

Learn more

Privacy Preference Center